To include your compound in the COVID-19 Resource Center, submit it here.

Apple Tree-backed Stoke launches with $40M A round

Stoke Therapeutics Inc. (Bedford, Mass.) emerged from stealth mode on Jan. 4 with a $40 million series A round from Apple

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE